NICE
NICE’s Rejection of Trikafta May Signal Price Dispute with Vertex in the UK
Vertex Pharmaceuticals faces a potential reiteration of history in the United Kingdom, where a recent decision by the National Institute ...
NICE approves Lilly’s Omvoh for ulcerative colitis after FDA rejection, citing cost-effectiveness and clinical benefits
“In a significant turn of events, Eli Lilly, despite initial setbacks in the US market with its ulcerative colitis drug ...
Pfizer’s Nurtec gets thumbs up from NICE for migraine attacks
England’s National Institute of Care and Health Excellence (NICE) has granted approval for Pfizer’s Vydura (rimegepant) as a treatment for ...
Keytruda Gets Green Light from NHS for New Cancer ‘Basket’
MSD’s Keytruda (pembrolizumab) has secured a significant recommendation from the UK’s National Institute for Health and Care Excellence (NICE), signaling ...
Despite CSL’s hemophilia B gene therapy, NICE is not persuaded
The UK’s National Institute for Health and Care Excellence (NICE) has expressed hesitation in recommending approval for CSL Behring and ...
NICE is adamant about rejecting a medicine for a rare condition
The UK’s National Institute for Health and Care Excellence (NICE) has issued its final verdict on Clinuvel’s Scenesse, a treatment ...
National Institute for Health and Care Excellence remains skeptical about the effectiveness of Mounjaro for diabetes
Eli Lilly has received positive data for its experimental obesity therapies, but in the UK, it faced a setback as ...
